Your session is about to expire
← Back to Search
Ultrasound Therapy
Transcranial MRgFUS for Movement Disorders
N/A
Waitlist Available
Led By Andres Lozano, MD
Research Sponsored by InSightec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the time of exablate procedure
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether a new MRI-guided procedure can help people with hard-to-treat movement disorders by targeting areas of the brain responsible for the symptoms.
Eligible Conditions
- Tardive Dyskinesia
- Essential Tremor
- Movement Disorders
- Limb Dystonia
- Huntington's Disease
- Parkinson's Disease
- Holmes Tremor
- Wilson's Disease
- Dystonia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at the time of exablate procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the time of exablate procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Severity of Device and Procedure Related Complications
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Transcranial ExAblate SystemExperimental Treatment1 Intervention
Transcranial ExAblate System (MRgFUS)
Find a Location
Who is running the clinical trial?
InSightecLead Sponsor
91 Previous Clinical Trials
3,788 Total Patients Enrolled
Andres Lozano, MDPrincipal InvestigatorSunnybrook Health Sciences Centre
1 Previous Clinical Trials
10 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of bleeding inside the brain.You have had a seizure in the past year.You have a low platelet count or a bleeding disorder that could cause problems during or after surgery.People with brain tumors.You have an infection that is not under control.You have had deep brain stimulation (DBS) or a specific type of brain surgery in the past.You have a weakened immune system, such as being HIV positive.People who are between 18 and 85 years old, including both men and women.You have a history of unusual bleeding or blood clotting issues.You have had multiple strokes or a stroke within the past 6 months.You have symptoms like headache, nausea, and vision problems caused by increased pressure inside your head.You cannot or do not want to stay lying down for a long time during treatment.You have a different type of brain disease like multisystem atrophy, progressive supranuclear palsy, dementia with Lewy bodies, or Alzheimer's disease.You have a mental illness that is not well controlled, or you experience psychosis.You have a serious illness that could be life-threatening.You have sleep apnea that has not been treated or controlled.You have unstable heart conditions, recent heart attack, congestive heart failure needing medication, or severe high blood pressure.You have metal devices inside your body that are not safe for MRI scans.You have a movement disorder that has not improved with treatment, as confirmed by a movement disorder specialist.You have tried the standard treatments for movement disorders recommended by a specialist doctor and they didn't work for you.You can tell the doctor how you feel during the ExAblate Neuro treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Transcranial ExAblate System
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger